Additionally, KRAS mutation seem to be associated with unfavorable outcomes making KRAS both a predictive and a prognostic marker in NSCLC [3], although its predictive role is still inconclusive as indicated by several recent studies [4]. This evidence concerns the gene KRAS and non-small cell lung carcinoma.